Catalyst Pharmaceuticals, Inc. (CPRX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Catalyst Pharmaceuticals, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 13.32x | 15.08x | 25.02x | 23.14x | 17.73x | 4.61x |
| P/B Ratio | 2.99x | 3.40x | 4.61x | 6.40x | 3.38x | 2.04x |
| P/S Ratio | 4.85x | 5.03x | 4.49x | 8.98x | 4.97x | 2.90x |
| Profitability | ||||||
| Gross Margin | 85.2% | 86.0% | 86.9% | 83.9% | 84.5% | 85.7% |
| Operating Margin | 43.8% | 39.7% | 21.8% | 47.5% | 37.2% | 34.7% |
| Net Margin | 36.4% | 33.3% | 17.9% | 38.8% | 28.0% | 63.0% |
| EBITDA Margin | 50.2% | 47.4% | 30.1% | 48.1% | 37.3% | 34.8% |
| Liquidity | ||||||
| Current Ratio | 6.08x | 5.17x | 2.88x | 5.57x | 7.76x | 7.00x |
| Quick Ratio | 5.82x | 5.01x | 2.68x | 5.45x | 7.47x | 6.79x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.00x |
YoY = year-over-year change. Source: FMP..